Jun 2025

23andMe's Fatal Flaw | Guess Who’s Back | 3

Just when it looked like 23andMe was selling to Regeneron Pharmaceuticals, founder Anne Wojcicki placed a bid through her new nonprofit in an attempt to win it back at the eleventh hour. Lila MacLellan, Senior Writer at Fortune, joins David to discuss Wojcicki’s leadership style, ... Show More

37m 55s

Jun 2025

Rebuilding LEGO | A Burning Platform | 1

It’s early 1997, and after decades of success, LEGO is rocked by a sudden collapse in its profit. To recover, the Danish toy manufacturer jacks up its innovation efforts. But can it deliver a company-saving idea in time?Be the first to know about Wondery’s newest podcasts, curate ... Show More

41m 39s

Jul 2025

Rebuilding LEGO | Brick to the Future | 2

It’s late 2003 and LEGO’s turnaround strategy has failed. It’s hurtling towards bankruptcy. Its only hope now is a three-man shadow leadership team. And they’re about to learn that the problems at LEGO go way deeper than anyone thought.Be the first to know about Wondery’s newest ... Show More

40m 8s

Apr 2024

Extra: Why Is 23andMe Going Under? (Update)

<p>Five years ago, we published an episode about the boom in home DNA testing kits, focusing on the high-flying firm 23andMe and its C.E.O. Anne Wojcicki. Their flight has been extremely bumpy since then. This update includes an additional interview with the <i>Wall Street Journa ... Show More

1h 2m

Aug 2024

How 23andMe went from a $6 billion valuation to trading for pennies

Cofounder and CEO of 23andMe, Anne Wojcicki, wants to take the public company private. Founded in 2006, the DNA-testing startup was valued at $6 billion in 2021. Now, it’s trading for less than a dollar. So what happened? ‘Fast Company’ senior writer Ainsley Harris breaks down 23 ... Show More

54m 45s

May 2021

CEO Series: 23andMe’s Anne Wojcicki on Scientific Breakthroughs and Public Trust

Anne Wojcicki, CEO of 23andMe, spent a decade in healthcare and biotechnology before launching the DNA testing and analysis company in 2006. Her goal was twofold: to help individuals learn more about their own genetics, enabling them to pursue more personalized medical care, and ... Show More

23m 55s

Mar 2025

The rise and fall of DNA testing company 23andMe

The genetic testing firm 23andMe has filed for bankruptcy, another twist in the story of a company that promised a pioneering approach to precision health. Now users are scrambling to delete their personal data, with the future ownership of the firm uncertain. To understand the h ... Show More

21m 49s

Jun 2025

When a home DNA testing company fails...

What happens to our data once it's been handed over to DNA testing companies? One such firm, 23andMe, filed for bankruptcy earlier this year. The company was set up to help people could track their ancestry - one of a number of similar sites using DNA data to create links and mat ... Show More

17m 28s

Apr 2025

How 23andMe's bankruptcy led to a run on the gene bank

Reporter Alexi Horowitz-Ghazi's Aunt Vovi signed up for 23andMe back in 2017, hoping to learn more about the genetic makeup of her ancestors. Vovi was one of over 15 million 23andMe customers who sent their saliva off to be analyzed by the company. But last month, 23andMe filed f ... Show More

30m 58s

Sep 2024

Encore: Theranos | The Walgreens Deal | 2

Theranos prepares to go public with its blood-testing devices. But the company faces increased scrutiny, as problems with its technology—and its leadership—add up.Need more American Scandal? With Wondery+, enjoy exclusive seasons, binge new seasons first, and listen completely ad ... Show More

36m 41s

Apr 2025

DNA and Bankruptcy Collide With 23andMe

The genetic testing company 23andMe filed for bankruptcy in March, after years of slowing sales, legal trouble, and a declining stock price. And now, the valuable trove of genetic data the company owns is for sale, sparking privacy concerns. On today’s Big Take, Bloomberg biotec ... Show More

16m 30s

23andMe's Fatal Flaw | Defying Gravity? ...